In summary, by its actions and inactions, the TGA has stymied the availability of data to the Department of Health and Ageing in relation to the magnitude of the DES problem in Australia
Great disappointment from Down Under! Australian Senate PIP Inquiry rejects DES story’s correlation to PIP breast implant scandal … This is tragic for PIP recipients and all other victims of drug/medical device disasters. Kudos to DES Activist Carol Devine for making a submission about the Therapeutic Goods Administration’s (TGA) mismanagement of the DES drug disaster and how this correlates to the TGA’s current handling of the PIP scandal. It’s so disheartening for DES Activists all over the world … What will it take for the DES story to be heard and its lessons to be learned …?????
“Don’t worry, be happy” slogan could harm your baby
A “Must Read” article!
“Drugs such as thalidomide or DES (diethylstilbestrol) were given to pregnant women with disastrous consequences and so downplaying those examples by claiming that we do things differently today seems a key strategy for drug companies“
says Alan Cassels a drug policy researcher at the University of Victoria.
Read “Don’t worry, be happy” slogan could harm your baby – DRUG BUST ” Pregnant Women Beware ” by Alan Cassels.
Embodied Knowledge and the Transformation of Women’s Health Politics
In DES Daughters, Susan Bell recounts the experiences of this generation of DES-victims. In moving, heartfelt narratives, she presents the voices of those women who developed cancer, those who were cancer-free but have concerns about becoming pregnant, and those who suffered other medical and/or reproductive difficulties.
What Bowdoin Books says
” Susan Bell‘s book tells a story about women who attained legendary status in the annals of medicine. They were exposed prenatally to what was promoted as a benign and exciting new wonder drug prescribed to millions of American women to prevent miscarriage from the 1940s to the 1970s. This new reproductive technology—the synthetic estrogen DES— proved to be ineffective in preventing miscarriage, and in the long run it has had profound and damaging consequences for children, especially daughters of the women for whom it was prescribed (Dieckmann et al. 1953; Giusti, Iwamoto, and Hatch 1995). In 1971, medical scientists observed an association between prenatal exposure to DES and a rare form of vaginal cancer (clear cell adenocarcinoma) in women under age twenty; using available medical categories, they identified this synthetic estrogen as the first “transplacental carcinogen” (Herbst, Ulfelder, and Poskanzer 1971). “DES Daughters”, as these women are now called, are also at risk for poor reproductive outcomes, including ectopic pregnancy, miscarriage, premature birth, and stillbirth (Giusti, Iwamoto, and Hatch 1995). Almost forty years later, DES-related cancer remains rare, but reproductive tract problems—including menstrual irregularities, poor reproductive outcomes, and structural or cellular anomalies—are common among DES Daughters. ” Sources: Bowdoin Books
“Exposure to artificial estrogens such as BPA and DES can change the way the fetus responds to estrogen later in life and may be associated with breast cancer” says Dr. Hugh Taylor, director of the Yale Center for Reproductive Biology.